A Study of Adalimumab in Japanese Subjects With Intestinal Behçet's Disease

NCT01243671 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Intestinal Behçet's Disease

Interventions

BIOLOGICAL: Adalimumab

Sponsor

AbbVie (prior sponsor, Abbott)

Collaborators

[object Object]